Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Apremilast for Pruritus in Psoriasis
NCT07432386Phase 4Not yet recruiting
- Start
- May 2026
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast, methotrexate in psoriasis. Planned start May 2026; status: not yet recruiting.
02
Drugs
apremilastmethotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07432386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432386.